UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
July 28, 2004
Date of Report (Date of earliest event reported)
APPLERA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 1-4389 | 06-1534213 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File No.) |
(IRS Employer Identification No.) |
301 Merritt 7
Norwalk, Connecticut 06851
(Address of Principal Executive Offices, Including Zip Code)
(203) 840-2000
(Registrant’s telephone number, including area code)
| Item 7. | Financial Statements and Exhibits. |
| (c) Exhibits. | |
| The following exhibits are filed with this Report: |
| Exhibit No. | Description | ||
| 99.1 | Press Release issued July 28, 2004, with respect to financial results for Applera Corporation and Applera’s Applied Biosystems Group. | ||
| 99.2 | Press Release issued July 28, 2004, with respect to financial results for Applera Corporation and Applera’s Celera Genomics Group. |
| Item 12. | Results of Operations and Financial Condition. |
On July 28, 2004, Applera Corporation (“Applera”) announced financial results for Applera and its business units for the fourth quarter of its 2004 fiscal year and for its full 2004 fiscal year. Attached hereto as Exhibit 99.1 and incorporated by reference herein is the text of a press release issued on July 28, 2004, with respect to financial results for the fourth quarter of fiscal year 2004 and the full 2004 fiscal year of Applera and Applera’s Applied Biosystems Group, and attached hereto as Exhibit 99.2 and incorporated by reference herein is the text of a press release issued on July 28, 2004, with respect to financial results for the fourth quarter of fiscal year 2004 and the full 2004 fiscal year of Applera and Applera’s Celera Genomics Group.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| APPLERA CORPORATION | ||
| By: | /s/ Dennis L. Winger | |
| Dennis L. Winger Senior Vice President and Chief Financial Officer |
||
Dated: July 28, 2004
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press Release issued July 28, 2004, with respect to financial results for Applera and Applera’s Applied Biosystems Group. | |
| 99.2 | Press Release issued July 28, 2004, with respect to financial results for Applera and Applera’s Celera Genomics Group. |